Advertisement

Topics

Akorn's stock soars after FDA approves ANDA for eyelash treatment Bimatoprost

05:58 EDT 10 Oct 2018 | Proactive Investors

The generic drug maker will manufacture the Bimatoprost ophthalmic solution in its New York facility

Original Article: Akorn's stock soars after FDA approves ANDA for eyelash treatment Bimatoprost

NEXT ARTICLE

More From BioPortfolio on "Akorn's stock soars after FDA approves ANDA for eyelash treatment Bimatoprost"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...